In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease
- 30 April 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 80 (3) , 544-552
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Advances in Understanding and Managing Dry Eye DiseaseAmerican Journal of Ophthalmology, 2008
- Uses and safety profile of ciclosporin in ophthalmologyExpert Opinion on Drug Safety, 2008
- Changes in the tear film and ocular surface from dry eye syndromeProgress in Retinal and Eye Research, 2004
- Molecular effects of cyclosporine and oncogenesis: a new modelMedical Hypotheses, 2004
- Cyclosporine A delivery to the eye: A pharmaceutical challengeEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- Utility assessment among patients with dry eye diseaseOphthalmology, 2003
- Molecular targets for existing and novel immunosuppressive drugsExpert Reviews in Molecular Medicine, 2000
- Mechanisms of action of cyclosporineImmunopharmacology, 2000
- Cyclosporin A Increases Tear Fluid Secretion via Release of Sensory Neurotransmitters and Muscarinic Pathway in MiceExperimental Eye Research, 1999
- Effect of Cyclosporin A Eyedrops on Tear Secretion in RabbitJapanese Journal of Ophthalmology, 1998